Cargando…
A prospective, randomized, double-blind trial to compare body weight-adjusted and fixed doses of palonosetron for preventing postoperative nausea and vomiting in obese female patients
BACKGROUND: Postoperative nausea and vomiting (PONV) is a common postsurgical complication. Palonosetron is effective for PONV prevention at the usual dose of 75 μg, but the ideal dose for obese patients has not yet been investigated. The aim of this study was to compare body weight-adjusted and fix...
Autores principales: | Gouveia de Araujo Ferreira, Nathalia, Cavalcanti, Ismar Lima, Assad, Alexandra Rezende, Barrucand, Louis, Braga, Estêvão Luiz Carvalho, Verçosa, Nubia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6959980/ https://www.ncbi.nlm.nih.gov/pubmed/31935249 http://dx.doi.org/10.1371/journal.pone.0227490 |
Ejemplares similares
-
Comparative Study Between Fosaprepitant and Palonosetron in the Prophylaxis of Postoperative Nausea and Vomiting in Women Undergoing Laparoscopic Cholecystectomy: Prospective, Randomized and Double-Blind Study
por: Braga, Estêvão Luiz Carvalho, et al.
Publicado: (2022) -
Management of postoperative nausea and vomiting: focus on palonosetron
por: Muchatuta, Neil A, et al.
Publicado: (2009) -
Effects of rocuronium, sugammadex and rocuronium-sugammadex complex on coagulation in rats
por: Lima Cavalcanti, Ismar, et al.
Publicado: (2020) -
Implementing a chronic pain ambulatory care: preliminary results
por: de Castro, Silvana, et al.
Publicado: (2019) -
Comparison of palonosetron with combined palonosetron and midazolam for preventing postoperative nausea and vomiting after laparoscopic cholecystectomy
por: Choi, Eun Kyung, et al.
Publicado: (2021)